Date & Time
October 23, 2023
Seattle Children's Building Cure, 1920 Terry Avenue, Seattle
Seattle Children's Research Institute’s Innovator Award winner, Dr. Aviv Regev, head of Genentech Research and Early Development and co-leader of the Human Cell Atlas project, will address "Cell Atlases as Roadmaps to Understand and Treat Disease" October 23 in Seattle. The lecture, followed by a reception, will begin at 3:30 pm at the Seattle Children's Building Cure at 1920 Terry Avenue.
Space is limited SCRI recommends people RSVP here and to expedite check-in. Contact SCRI@seattlechildrens.org with any questions.
Dr. Regev is a computational and systems biologist and a pioneer of single cell genomics. Her work has led to a greater understanding of how cells function and how they malfunction in disease.
Regev joined Genentech in August 2020 and is responsible managing gRED’s drug discovery and drug development activities. She also serves on the Genentech Executive Committee and Board of Directors, and is a member of the expanded Corporate Executive Committee for Roche. She also runs a research lab focused on developing and applying experimental methods and computational algorithms to decipher intra- and intercellular circuits in cells in tissues.
Regev currently is on leave from the Broad Institute of MIT and Harvard. She also is a founding co-chair of the Human Cell Atlas.